Jeannie McClelland

New Treatment for Tough Disease

1 post in this topic

New Treatment for Tough Disease. Researchers at Northwestern University Feinberg School of Medicine found that rosiglitazone, a treatment commonly used in type-2 diabetes, may reduce the severity of scleroderma. (Huliq) The American Journal of Pathology. February 2009. (Also see: Scleroderma Treatments)

 

This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.


Jeannie McClelland

(Retired) ISN Director of Support Services

(Retired) ISN Sclero Forums Manager

(Retired) ISN Blog Manager

(Retired) ISN Assistant News Guide

(Retired) ISN Artist

International Scleroderma Network

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now